MAPK3 and breast carcinoma: Subsequent in vitro investigations revealed a significant reduction in the expression levels of p-EGFR, p-AKT, and p-ERK1/2 proteins, underscoring the pivotal functions of EGFR, PI3K/Akt, and MAPK signaling pathways in SP’s anti-breast cancer properties.